http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109646440-B

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4985
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4985
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-02
filingDate 2019-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2021-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2021-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-109646440-B
titleOfInvention Application of Cabotegravir in the preparation of anti-bovine infectious rhinotracheitis drug
abstract The invention provides the application of Cabotegravir in the preparation of anti-bovine infectious rhinotracheitis medicine. It is found for the first time in the present invention that the compound Cabotegravir can effectively inhibit the proliferation of bovine infectious rhinotracheitis virus, and has less toxicity to cells. It has been proved by experiments that the median toxicity concentration (CC 50 ) of Cabotegravir to MDBK cells is greater than 100 μM, while the toxicity to bovine infectious rhinotracheitis virus is small. The median effective concentration (EC 50 ) of rhinotracheitis virus is 1.419 μM; the therapeutic index of Cabotegravir to bovine rhinotracheitis virus is greater than 70.47, indicating that it has the prospect of being developed into an anti-bovine rhinotracheitis drug, which is Cabotegravir It opens up new drug uses, and also lays the experimental foundation and provides new horizons for the development of efficient and specific anti-IBRV drugs.
priorityDate 2019-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3363802-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559357
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID260
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559198
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419594684
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6395
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419522894
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426146645
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410746595
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412584819
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1118
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6422
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407378349
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6925
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6452212
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54713659
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID944

Total number of triples: 37.